Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Farrell Michael J.
 2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2010		 3. Issuer Name and Ticker or Trading Symbol
RESMED INC [RMD]
(Last)
(First)
(Middle)
9001 SPECTRUM CENTER BLVD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Sr. Vice President
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN DIEGO, CA 92123		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
ResMed Common Stock 1
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed NQ Stock Options 02/03/2007(1) 02/03/2016 ResMed Common Stock 15,000 $ 38.5 D  
ResMed NQ Stock Options 11/10/2007(1) 11/10/2013 ResMed Common Stock 17,000 $ 46.19 D  
ResMed NQ Stock Options 08/01/2008(1) 08/01/2014 ResMed Common Stock 25,000 $ 43.42 D  
ResMed NQ Stock Options 11/07/2008(1) 11/07/2014 ResMed Common Stock 4,000 $ 42.05 D  
ResMed NQ Stock Options 10/01/2009(1) 10/01/2015 ResMed Common Stock 10,000 $ 43.35 D  
ResMed NQ Stock Options 11/20/2009(1) 11/20/2015 ResMed Common Stock 55,000 $ 31.04 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Farrell Michael J.
9001 SPECTRUM CENTER BLVD
SAN DIEGO, CA 92123		       Sr. Vice President  

Signatures

Michael J. Farrell, Sr. Vice President of Sleep Strategic Business Unit 03/01/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Options vest 1/4 annually on the anniversary of the grant. Represents date options first became exercisable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.